Navigation Links
NexGenix Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Date:11/1/2007

NEW YORK, Nov. 1 /PRNewswire/ -- NexGenix Pharmaceuticals, a privately held biotechnology company focused on developing drugs to treat the orphan- designated tumor suppressor disorder neurofibromatosis and related sporadic tumors, today announced that Allan E. Rubenstein, MD, Chief Executive Officer of NexGenix will be presenting at the Acumen BioFin and Rodman & Renshaw 9th Annual Healthcare Conference at 3:00 pm on November 5th, 2007 at the New York Palace Hotel. Dr. Rubenstein will be providing an overview of NexGenix and discussing recent company highlights.

The Acumen BioFin and Rodman & Renshaw 9th Annual Healthcare Conference will include presentations by over 350 companies, as well as experts from the medical, scientific and investment communities. The Conference will be attended by investors, venture capitalists, company executives, scientists and other industry leaders.

About NexGenix Pharmaceuticals

NexGenix Pharmaceuticals is a US-based biotechnology company focused on drug development for Neurofibromatosis Types 1 and 2 and related sporadic tumors. Neurofibromatosis, or NF, is a genetic disorder characterized by the development of tumors along nerves. NexGenix has assembled a team of top NF clinicians and researchers on its Scientific Advisory Board and has developed a proprietary screening platform for both Neurofibromatosis Type 1 and 2. NexGenix will soon seek an IND for a unique treatment for NF1.

For more information, please visit the NexGenix website at http://www.nexgenixpharm.com. The information on our website does not, however, form a part of this press release.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities la
'/>"/>

SOURCE NexGenix Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... Final Cut Pro X ... Film Studios, entitled TranSports. , “TranSports is a ... Cut Pro X,” said Christiana Austin, CEO of Pixel ... to effortlessly transition using this cool sports transition tool.” ... uniquely styled transition pack for Final Cut Pro X. ...
(Date:3/28/2015)... Coffee could not only perk you up in ... disease, researchers have found. , They found that those who ... antioxidants. Antioxidants fight gum disease. Does coffee, then, help fight ... Henry M. Goldman School of Dental Medicine explored in a ... the Journal of Periodontology. , “This is the first long-term ...
(Date:3/28/2015)... March 28, 2015 With more ... the fields of osteoporosis, osteoarthritis and musculoskeletal diseases ... it may be the first time in the ... forum that the hot-button topic is an emerging ... the well-accepted scientific principles of Wolff’s law, osteogenic ...
(Date:3/28/2015)... India Network visitor health insurance announced ... visitors who purchase the plan before arrival in the ... purchase the insurance program as soon as travel plans ... pre-existing medical conditions. Parents and grandparents traveling from India ... serious consequences to their health. Many visitors may not ...
(Date:3/28/2015)... 28, 2015 One in three young ... research presented today at the American Orthopaedic Society for ... examined the long term success of surgery for patients ... survey data from 242 patients who underwent ACL reconstruction ... Roe, MBBS, FRACS, from North Sydney Orthopaedic and Sports ...
Breaking Medicine News(10 mins):Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2
... a new study finds, , , THURSDAY, March 13 (HealthDay ... in children, especially the very youngest, new research contends. ... to 14 years old, showed that environmental tobacco exposure ... of vascular injury, suggesting an increased risk of heart ...
... with the Strategic Placement, of Banners during this ... this Year,s Field utilize SURGEX(TM) to Compliment Their ... Millennium,Biotechnologies Inc., wholly-owned subsidiary of Millennium Biotechnologies,Group, ... many PGA,players and spectators will be introduced to ...
... Va., March 13 An ALFA initiative,to eliminate the ... in,assisted living communities was filed today on Capitol Hill., ... (R-21st FL) and,twelve other House members are sponsoring HR ... Equity Act of 2008. This bipartisan,measure corrects an apparent ...
... new campaign is underway to help,raise awareness of ... of America, or ADAA, has launched the "Treat ... to educate Americans about,OCD symptoms and treatment options., ... Disorders Association of America,at: http://media.medialink.com/WebNR.aspx?story=34804 , ...
... SAUSALITO, Calif., March 13 Take Care Health ... clinics and a wholly-owned,subsidiary of Walgreens (NYSE, Nasdaq: ... & Partners (BSSP), a full-service marketing,communications firm headquartered ... of record., BSSP is tasked with developing ...
... Marathon Mark Leventhal, Esq.,Founder and President ... -- the first in the nation ... an attorney -- is featured on,the cover ... ("YL") in an article,entitled "Accessible Accountability: Attorney,s ...
Cached Medicine News:Health News:Secondhand Smoke Hikes Tots' Risk of Heart Disease 2Health News:Secondhand Smoke Hikes Tots' Risk of Heart Disease 3Health News:SURGEX(TM) Joins the Team of Sponsors for the PGA Tour's 2008 Arnold Palmer Invitational Presented by MasterCard 2Health News:SURGEX(TM) Joins the Team of Sponsors for the PGA Tour's 2008 Arnold Palmer Invitational Presented by MasterCard 3Health News:SURGEX(TM) Joins the Team of Sponsors for the PGA Tour's 2008 Arnold Palmer Invitational Presented by MasterCard 4Health News:ALFA Aims to Provide Relief to Seniors 2Health News:Take Care Health Systems Names Butler, Shine, Stern & Partners as First Marketing Agency of Record 2Health News:Take Care Health Systems Names Butler, Shine, Stern & Partners as First Marketing Agency of Record 3Health News:Leventhal Weight Loss President Featured on Cover of Young Lawyer 2
(Date:3/27/2015)... BioCorRx, Inc. ( BICX ... is a healthcare solutions organization, which focuses solely on ... billion in the U.S. alone. The Company created a unique ... a specially compounded form for outpatient surgical implantation. The Company ... New Zealand ) to the specially formulated ...
(Date:3/27/2015)... March 27, 2015  The quality function within the ... products meet quality standards at every stage of the ... quality leaders also have the challenge of balancing quality ... Those who don,t effectively balance these priorities risk funding ... marketplace failure and regulatory scrutiny. For the ...
(Date:3/27/2015)... 27, 2015 Levi & Korsinsky announces it ... OHRP ) concerning possible violations of federal securities ... Company in connection with its study of the drug ... or contact Joseph E. Levi, Esq. ... telephone at (212) 363-7500, toll-free: (877) 363-5972. ...
Breaking Medicine Technology:Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S. 2New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2
... Prometheus Laboratories Inc., a,specialty pharmaceutical company, today ... Diagnostic, the first and only blood test,for ... measurable,differences in the expression of particular biomarkers ... The identification of these biomarkers,combined with a ...
... polyps that can be ... missed during colonoscopy, ... Annual Scientific Meeting in Orlando (ACG 2008), renowned,gastroenterologist Douglas K. ... the efficacy of the Third,Eye(R) Retroscope(R), a new device that ...
Cached Medicine Technology:Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5
... is the highly concentrated multi-purpose detergent ... or with an ultrasonic cleaner. ... blood and organic material and safe ... to clean surgical instruments manually or ...
... need for critical patients more waveforms, ... comprehensive calculations package and cardiac output ... can transport with your patients., We ... functions which means less time ...
The ApexPro CH is operational within the WMTS. It offers operating performance, up to 240 WMTS channels, and up to 120 hours of battery life....
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
Medicine Products: